The FDA approves zuranolone, a new option for the treatment of PPD, a rapidly acting antidepressant with a good safety profile.
The post New Oral PPD Treatment Zuranolone Will Soon Hit the Market as Zurzuvae appeared first on MGH Center for Women’s Mental Health.